shRNA-treated islets. The cumulative frequency of Fluo-2 intensity values (AU, arbitrary units) at 3 mM glucose is not significantly altered by ADCY5 knockdown (P>0.05; two-way ANOVA).
Supplementary Figure 2. Donor age and BMI do not alter the magnitude suppression of glucosestimulated insulin release following ADCY5-silencing. (A)
Age
Supplementary Figure 6. ADCY5 does not alter Ca
2+ responses to depolarisation. (A) KCl (30 mM) elicits similar responses in control (Con) and shRNA-treated islets (left panel, representative traces) (gray/black, raw; red, smoothed) (G3, 3 mM glucose) (NS, non-significant; Mann-Whitney U-test) (n = 4 recordings). (B) As for (A) but in the continued presence of diazoxide (Dz) 500 µM to limit complications arising from changes in plasma membrane potential (n = 10 recordings). Values represent mean ± SEM. 
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